90
Participants
Start Date
January 12, 2015
Primary Completion Date
May 22, 2018
Study Completion Date
May 22, 2018
INO-1800
INO-1800 delivered by EP
INO-9112
INO-9112 delivered by EP
Nucleos(t)ide Analogue Treatment
Continued treatment with nucleos(t)ide analogue
Taipei Veterans General Hospital, Taipei
Chang Gung Memorial Hospital, Linkou District
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Auckland City Hospital, Auckland
The Medical City, Pasig
Nepean Hospital, Kingswood
Mater Adult Hospital, South Brisbane
Royal Adelaide Hospital, Adelaide
National Taiwan University Hospital, Taipei
Mount Sinai - PRIME, New York
Siriraj Hospital, Mahidol University, Bangkoknoi
Northwell Health, Manhasset
Philadelphia VA Medical Center, Philadelphia
University of Miami Schiff Center for Liver Disease, Miami
Srinagarind Hospital, Khon Kaen
Taichung Veterans General Hospital, Taichung
UC Physicians Company, LLC/Division of Digestive Diseases, Cincinnati
Maharaj Nakorn Chiang Mai Hospital, Tha Muang
Research and Education, Inc., San Diego
Harbourview Medical Center, Seattle
Singapore General Hospital, Singapore
The University of Hong Kong, Hong Kong
Lead Sponsor
Inovio Pharmaceuticals
INDUSTRY